NEW YORK (GenomeWeb News) – Following last week’s merger of Applied Biosystems and Invitrogen to create Life Technologies, the combined firm has appointed three former directors of ABI to its board: Arnold Levine, George Adam, and William Longfield.
 
Levine will serve as a member of the board’s Science and Technology Committee, Adam will serve as a member of the Audit Committee, and Longfield will serve as a member of the Compensation and Organizational Committee.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.